Impact of prostate cancer testing: An evaluation of the emotional consequences of a negative biopsy result

British Journal of Cancer

Volumn 102, Issue 9, 2010, Pages 1335-1340

  MacEfield, R C ^a   Metcalfe, C ^a   Lane, J A ^a   Donovan, J L ^a   Avery, K N L ^a   Blazeby, J M ^a   Down, L ^a   Neal, D E ^b   Hamdy, F C ^c   Vedhara, K ^d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Prostate biopsy; PSA testing; Psychological distress; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANXIETY; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; DISTRESS SYNDROME; ETHNICITY; FAMILY HISTORY; FOLLOW UP; HUMAN; IMPACT OF EVENTS SCALE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; STATISTICAL ANALYSIS;

AFFECT; AGED; ANGER; BIOPSY; CONFUSION; DEPRESSION; EMOTIONS; FATIGUE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; STRESS, PSYCHOLOGICAL; TREATMENT REFUSAL;

EID: 77951666641     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605648     Document Type: Article

References (30)

1. Abrahamsson PA, Artibani W, Chapple CR, Wirth M (2009) European Association of urology position statement on screening for prostate cancer. Eur Urol 56(2): 270-271
2. Andriole GL, Grubb RLI, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, Crawford ED, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13): 1310-1319
3. Andrykowski MA, Boerner LM, Salsman JM, Pavlik E (2004) Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study. Health Psychol 23(6): 622-630
4. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJTh (2000) False-positive findings in mammography screening induces short-term distress-breast cancer-specific concern prevails longer. Eur J Cancer 36: 1089-1097
5. Avery KNL, Blazeby JM, Lane JA, Neal DE, Hamdy FC, Donovan JL (2008a) Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial. Eur Urol 53: 1186-1193
6. Avery KNL, Metcalfe C, Blazeby JM, Lane JA, Neal D, Hamdy FC, Donovan J (2008b) Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations? BJU Int 102(11): 1629-1633
7. Awsare NS, Green JSA, Aldwinckle B, Hanbury DC, Boustead GB, McNicholas TA (2008) The measurement of psychological distress in men being investigated for the presence of prostate cancer. Prostate Cancer Prostatic Dis 11(4): 384-389
8. Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, Lane JA, Peters TJ (2006) Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int 98: 777-782
9. Carlsson S, Aus G, Wessman C, Hugosson J (2007) Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA)-results from a prospective, population-based, randomised study. Eur J Cancer 43: 2109-2116
10. Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, Neal D, Hamdy F, Stephens P, Lane JA, Moore R, Donovan J (2008) Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9(5): 445-452
11. Davison AC, Hinkley DV (1997) Bootstrap Methods and Their Application. Cambridge University Press: Cambridge
12. Donovan JL, Hamdy FC, Neal DE, Peters TJ, Oliver SE, Brindle LA, Jewell D, Powell P, Gillatt D, Dedman D, Mills N, Smith MA, Noble S, Lane JA (2003) Prostate testing for cancer and treatment (ProtecT) feasibility study. Health Technol Assess 7(14): 1-49
13. Essink-Bot M-L, de Koning HJ, Nijs HGT, Kirkels WJ, van der Maas PJ, Schröder FH (1998) Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 90: 925-931
14. Fowler FJ, Barry MJ, Walker-Corkery B, Caubet J-F, Bates DW, Lee JM, Hauser A, McNaughton-Collins M (2006) The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioural, and medical care outcomes. J Gen Intern Med 21: 715-721
15. Frankel S, Davey Smith G, Donovan J, Neal D (2003) Screening for prostate cancer. Lancet 361: 1122-1128
16. Gustafsson O, Theorell T, Norming U, Perski A, Ohstrom M, Nyman CR (1995) Psychological reactions in men screened for prostate-cancer. Br J Urol 75(5): 631-636
17. Holmstrom B, Johansson M, Bergh A, Stenman UH, Hallmans G, Stattin P (2009) Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 339: b3537
18. Horowitz M, Wilner N, Alvarez MA (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3): 209-218
19. Joseph S (2000) Psychometric evaluation of Horowitz's impact of events scale: a review. J Trauma Stress 13(1): 101-113
20. Katz DA, Jarrard DF, McHorney CA, Hillis SL (2007) Health perceptions in patients who undergo screening and workup for prostate cancer. Urology 69(2): 215-220
21. Lowe JB, Balanda KP, Del Mar C, Hawes E (1999) Psychological distress in women with abnormal findings in mass mammography screening. Cancer 85: 1114-1118
22. Macefield RC, Lane JA, Metcalfe C, Down L, Neal DE, Hamdy FC, Donovan JL (2009) Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy? Eur J Cancer 45(14): 2569-2573
23. McNaughton-Collins M, Fowler FJ, Caubet J-F, Bates DW, Lee JM, Hauser A, Barry MJ (2004) Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med 117: 719-725
24. Melia J, Moss S, Johns L (2004) Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 94(1): 51-56
25. Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55(1): 79-86
26. Rosario DJ, Lane JA, Metcalfe C, Catto JW, Dedman D, Donovan JL, Neal DE, Hamdy FC, ProtecT SG (2008) Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study. Eur Urol 53(4): 777-784
27. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13): 1320-1328
28. Shacham S (1983) A shortened version of the profile of mood states. J Pers Assess 47(3): 305-306
29. Taylor KL, Shelby RA, Kerner J, Redd W, Lynch J (2002) Impact of undergoing prostate carcinoma screening on prostate carcinoma-related knowledge and distress. Cancer 95: 1037-1044
30. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6): 361-370